Related Experiment Video
Updated: Aug 9, 2026

Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development
Published on: July 13, 2014
Effects of methyl benzimidazolecarbamate during early pregnancy in the rat
A M Cummings1, S T Harris, G L Rehnberg
1Developmental Toxicology Division, U.S. Environmental Protection Agency, Research Triangle Park, North Carolina 27711.
Abstract:
Methyl 2-benzimidizolecarbamate (MBC), an agricultural fungicide, and its parent compound benomyl have adverse reproductive effects on male rats and exhibit embryotoxicity, including teratogenicity, when administered to rats during mid to late pregnancy. This study was designed to assess potential maternal effects of MBC during early pregnancy, to distinguish maternal from embryotoxic effects of the chemical, and to differentiate between early pregnancy failure and late embryonic loss. MBC was administered to rats by gavage at 0, 25, 50, 100, 200, 400, and 1000 mg/kg/day during Days 1 through 8 of pregnancy (Day 0 = sperm positive). A range of maternal and embryonic parameters was assessed following euthanasia on Day 9, including the number of implantation sites, body weight gain, uterine weight, implantation site size, and serum ovarian and pituitary hormones. In a separate experiment, pseudopregnant rats were administered 0 or 400 mg/kg/day MBC during Days 1-8, received bilateral uterine decidual induction on Day 4, and were killed on Day 9 at which time the decidual cell response was evaluated as a measure of uterine competency. When dosages of up to 400 mg/kg/day of MBC were administered during early pregnancy, the chemical had no significant effect on any measured parameter but a trend toward increased resorptions was evident. The 1000 mg/kg/day dosage of MBC produced reductions in body weight gain, implantation site weight, and serum LH and an increase in serum estradiol. When administered during pseudopregnancy, 400 mg/kg/day MBC partially reduced uterine decidual growth but affected no other parameter.(ABSTRACT TRUNCATED AT 250 WORDS)
Insights
Methyl 2-benzimidazolecarbamate (MBC) fungicide showed no maternal effects in early pregnancy at doses up to 400 mg/kg. Higher doses caused maternal toxicity and hormonal changes, impacting pregnancy outcomes.
Area of Science:
- Toxicology
- Reproductive Science
- Developmental Biology
Background:
- Methyl 2-benzimidazolecarbamate (MBC) and benomyl are agricultural fungicides.
- Previous studies indicate adverse reproductive and embryotoxic effects in male and pregnant rats.
Purpose of the Study:
- Assess maternal effects of MBC during early pregnancy.
- Differentiate maternal toxicity from embryotoxicity.
- Distinguish early pregnancy failure from late embryonic loss.
Main Methods:
- Rats received MBC (0-1000 mg/kg/day) during Days 1-8 of pregnancy.
- Maternal and embryonic parameters assessed on Day 9.
- Pseudopregnant rats tested for uterine competency with MBC exposure.
Main Results:
- No significant maternal or embryonic effects observed up to 400 mg/kg/day MBC.
- 1000 mg/kg/day MBC reduced body weight gain, implantation site weight, and altered LH and estradiol levels.
- MBC at 400 mg/kg/day partially reduced decidual growth in pseudopregnant rats.
Conclusions:
- MBC does not appear to cause maternal toxicity or early pregnancy failure at doses below 1000 mg/kg/day.
- High-dose MBC exposure can induce maternal toxicity and hormonal disturbances.
- Uterine competency may be affected by MBC, warranting further investigation.

